Table of Contents
If you’re coding for metastatic breast cancer in ICD-10, you have to be super careful with your documentation and show where the primary breast cancer and metastatic sites are. Coders need to do the right kind of documentation to do the right kind of coding, as well as make sure to do a comprehensive review of the entire medical documentation for the patient in order to do everything right. Knowing the coding rules, coding patterns, and frequent mistakes is beneficial to avoid the claim being denied, and to get proper reimbursement, and also to have good clinical data for proper treatment planning for the data to be used for health care reporting.
Metastatic breast cancer is defined by its spread from breast tissue to critical organs, which include the bones, lungs, liver, and the brain. Involved clinicians are limited in their ability to fully comprehend the scope of the disease, and the various health care policy and practice reimbursement systems are designed to restrict reimbursement to the degree that the policy and practice are poorly defined. Hence, the ICD-10-CM enacts a plethora of policy and practice reimbursement systems to describe the primary breast cancer and its associated secondary site(s).
Healthcare organizations are unable to submit a claim to their third-party payers for reimbursement of their services without the use of appropriate ICD-10 coding. appropriate coding for metastatic breast cancer demands that the coder be versed in the guidelines, i.e., the coding order of the group, and the documentation. In the absence of all of these variables, coders run the risk of failing to bring a claim to a timely and appropriate conclusion, and coders run the risk of working outside the provisions of the payer’s guidelines.
Metastatic Breast Cancer and the Clinical Documentations Involved
What is Metastatic Breast Cancer?
Metastatic breast cancer (stage IV breast cancer) means breast cancer cells have spread to other organs besides the breast and nearby lymph nodes. The term for this process is metastasis. Common areas for breast cancer to metastasize to include the bones, lungs, liver, and brain. Even when breast cancer spreads to different other organs, it is still referred to as breast cancer because the cancer originated in the breast tissues.
Importance of Physician Documentation
In the coding process, precise, clinical documentations are a great necessity in detail. Physician documentations detail the primary site of cancer, the stage of the disease, and the organs that are impacted by metastasis. This detail offers coders a foundation for reporting the primary malignancy and the associated secondary metastatic locations within valid ICD-10 codes.
How Documentations Lead to Correct Coding
If the physician documents the precise location of the primary breast tumor along with the metastatic locations, the coders can allocate the most accurate ICD-10 codes. Good documentation differentiates between whether the primary cancer is still active or whether it has gone into remission, and that affects coding and sequencing for that case.
Primary ICD-10 Codes for Breast Cancer
Overview of the C50 Category
The primary ICD-10 code for breast cancer is C50 (Malignant Excrescence of Breast). This code captures multiple anatomical descriptions concerning the primary location of the breast cancer for clinical reporting and treatment purposes.
Examples of Specific Breast Cancer Codes
The C50 code is classified into codes according to different regions and quadrants of the breast. For example, C50.0 is the code for malignant neoplasm of the nipple and areola, while C50.2 is the code for malignant neoplasm of the upper inner quadrant.
Importance of Laterality in Coding
When coding an ICD-10, a more complicated aspect is coding laterality of the offending breast. The malignancy could be located on the right, left, or middle of the breast. When it comes to keeping records, the middle position of a breast is of little relevance and can even deflect the focus concerning the disease and its management. However, the lateral position is of great relevance.
ICD-10 Codes for Secondary Cancer
Metastatic Cancer Coding
When coding ICD-10 for metastatic breast cancer, additional codes are needed to specify the affected organs. These codes must be classified within the parameters of C77, C78, and C79, which are for secondary malignant neoplasms of specified organs or systems.
Commonly Affected Organs and their Codes
The most common organs affected by breast cancer metastasis are bones, lungs, liver, and brain. For example, metastatic breast cancer that spreads to the bone is assigned the code C79.51, which refers to secondary malignant neoplasm of the bone. For breast cancer that spreads to the lungs, the code is C78.00, which refers to secondary malignant neoplasm of the lung. For metastasis of breast cancer to the liver, the code is C78.7, which refers to a secondary malignant neoplasm of the liver and intrahepatic bile duct.
Importance of Secondary Codes
The reason for coding the secondary metastatic sites is to show the full picture of the patient’s condition. These secondary codes demonstrate the seriousness of the condition to the physician, support accurate reimbursement for the healthcare facility, and contribute to the integrity of the research and statistics of the healthcare system.
ICD-10 Coding Instructions for Metastatic Breast Cancer
Classifying Primary and Secondary Malignancies
ICD-10 directs that when both the primary breast cancer and the site of metastasis are active, coders are to report both. In this way, the documentation of the patient’s diagnoses and the care they received is complete.
The Purpose of Code Order
The reason for the patient’s encounter determines code order. If the patient is there for treatment of the metastasized site, the secondary malignancy code is placed first, followed by the primary breast cancer code. Conversely, if the treatment is for the primary breast cancer, then the primary malignancy code is placed first.
Avoiding Unspecified Codes
If detailed documentation exists, coders are instructed to code with more specificity, and not to code with an unspecified code. If the physician documents the site of the tumor and where the metastases are, the coder should select the most specific code. This not only increases the likelihood of the claim being paid, but also improves the health-related data.
Coding Scenarios for Metastatic Breast Cancer
Example 1: Breast Cancer with Bone Metastasis
Consider the case of a patient with left-sided breast cancer, with metastasis to the bones. The coder will first assign a C50 code for left breast cancer. Subsequently, the coder will assign a code of C79.51 for secondary malignant neoplasm of the bone.
Example 2: Metastatic Disease of the Breast to the Lungs
Another case would be that of a patient with recurrent breast cancer that had been treated, with subsequent metastasis to the lungs. The coder would first assign a code for lung metastasis. Subsequently, she would assign the code of Z85.3 for a personal history of malignant neoplasm of the breast.
Example 3: Metastasis to Multiple Sites
Some patients have metastasis to different organs, including the liver and brain. Coders have to assign multiple ICD-10 codes for the spread of the disease.
Documentation Requirements for Accurate Coding
What Physicians Have to Document
For correct coding to happen, physicians have to document whether the breast cancer is primary, recurrent, or metastatic, and the location of the tumor within the breast and the locations where the tumor metastasized.
Recording Treatment Status
Another important piece of documentation is the cancer treatment status. Coders have to determine whether the primary cancer is still present or has been treated. If there is currently no cancer present, rather than an active malignancy code, a personal history code has to be used.
Supporting Evidence in Medical Record
Documentation can include imaging, pathology, biopsy, and oncology consultation reports. These reports help coders confirm the diagnosis and determine the appropriate ICD-10 codes.
Best Practices for Coding Metastatic Breast Cancer
Reviewing the Whole Patient Record
One of the best practices with coding is reviewing the entirety of the patient record. There may be documentation regarding the metastasis in imaging reports, pathology reports, or oncology reports, and it may be completely absent in the physician progress notes.
Coding Instructions
Every year the rules change, and in order to code metastatic cancers accurately, coders need to be aware of the most current yearly changes.
Provider Communication
In the event of vague documentation, the coder should seek clarification from the physician. Good communication between the coder and the physician creates a better environment for accurate coding and reduces the likelihood of errors in billing.
Engaging in Compliance Workshops and Coding Audits
Compliance training and coding audits should be done frequently. These audits and workshops help pinpoint repetitive mistakes, reinforce coding practices, and help staff to be in compliance with the most current decrees of the Healthcare Compliance laws.
Mistakes in Coding that Must be Avoided
Missing Metastatic Codes
One of the most common mistakes when coding breast cancer with distant metastasis is failing to code the metastatic site. Coding only the primary breast cancer is coding the patient’s condition incompletely.
Incorrect Code Sequencing
One of the most common errors while coding metastatic breast cancer is coding the primary cancer first when the visit is for metastatic treatment. Code sequencing is visit specific and must adhere to the ICD-10 coding guidelines.
Overuse of Unspecified Codes
Using unspecified codes when there is the potential for more detail lowers the quality of health care data and increases the chance of claim denials. Coders should adhere to the most specific code possible in the absence of supporting documentation.
Ignoring Personal History Codes
Use of personal history codes is warranted when the primary breast cancer is treated and inactive. Employing active malignancy codes would create inaccuracies in the medical records.
Final Thoughts
Inattentive metastatic breast cancer coding in ICD-10 is a consequence of poor documentation and a lack of adherence to the coding and sequencing guidelines. It is particularly important to accurately capture both the disease-breast cancer and metastatic locations when the disease is active.Coders must do a complete analysis of clinical documentation, engage in a targeted dialogue with clinical documentation, and above all, comply with ICD-10 coding standards and guidelines, in order to obtain precise reporting. The significance of the accuracy of coding to the reimbursement process to the healthcare system and to the enhancement of the services rendered to the patients is of equal importance.
Make An Appintment With A2ZFAQs
Metastatic breast cancer does not have a specific ICD-10 code. Coders have to code the primary breast cancer using the C50 category and the site where the metastases are using secondary malignant neoplasm codes C77-C79.
Yes. When primary breast cancer and the metastatic site are both active, ICD-10 guidelines state that it is necessary to code both in order to provide a true picture of the patient’s condition.
The reason for visit determines code order. If the treatment is focused on the metastases, the secondary cancer code can be the first code. If the treatment is for the primary breast tumor, the primary cancer code is sequenced first.
Breast cancer usually metastasizes to the liver, brain, lungs, and bones. Each of these sites has a particular ICD-10 code in the secondary malignant neoplasm categories.
Physicians are encouraged to document breast tumor location, laterality, sites of metastasis, and whether the primary cancer is active, or previously treated. Place clarity helps coders to accurately determine the specific ICD-10 code.